user
menu
letter
Sign InRegister
langEnglisharrow

IL-2 R alpha

IL-2 R alpha

IL-2 R alpha 분자 정보

Molecule Name
Interleukin-2 receptor alpha chain
분자 별명
IL2RA,CD25,p55,IL2-RA,IL-2-RA
Drug Development Progress
임상 약물 수16
시판 약물 수3
최고 연구 개발 단계Approved
표적 별명
TAC antigen，p55，IL2-RA，Interleukin-2 receptor subunit alpha，IL-2-RA，IL-2R subunit alpha，IL2RA，Interleukin 2 Receptor Subunit Alpha，Interleukin 2 Receptor， Alpha，IL-2 Receptor Subunit Alpha，Insulin-Dependent Diabetes Mellitus 10，CD25 Antigen，IDDM10，IMD41，TCGFR，CD25，Interleukin-2 Receptor alpha Subunit，IL-2R alpha
분자 배경
Interleukin-2 receptor subunit alpha (IL2RA) is also known as IL-2R subunit alpha, IL-2-RA, IL2-RA, TAC antigen, p55, CD antigen CD25, is a type I transmembrane glycoprotein. IL2RA is expressed on activated T cells and regulatory T cells, and is capable of binding IL2 with low affinity by itself. However, a ligand-induced high affinity heterotrimeric receptor complex is produced when IL2RA is associated non-covelently with the IL2 receptor beta and gamma chain, and subsequently initiates the intacellular signal pathways such as MAPK or JAK/STAT. On dendritic cells (DC), CD25 has been previously regarded as an activation marker, while both murine and human DC can express CD25, they do not express the beta-chain of the IL-2 receptor, which is indispensable for the execution of IL-2 signaling.

IL-2 R alpha 제품 목록

Species
  • Human（5）
  • Cynomolgus（2）
  • Mouse（2）
  • Canine（1）
  • Rat（1）
  • Rhesus macaque（1）
Tag
  • His Tag（7）
  • His Tag & Avi Tag（3）
  • Fc Tag（1）
  • Fc Tag & Avi Tag（1）
Host
  • HEK293（12）
Conjugate
  • Unconjugated（8）
  • Biotin-labeled（4）
Grade
  • RUO（11）
  • PG (pre-GMP)（1）
Low Endotoxin
  • Yes（3）
  • No（9）
분자Cat. No.Product Name종Host구조순도Activity규격 및 가격
IL-2 R alpha
AIDD‑Ready
ILA-H52H9AI
Human IL-2 R alpha / CD25 Protein, His Tag
Human
HEK293
MALSSDS-PAGE
SPR

$1080.00

250ug
IL-2 R alpha
HOT
ILA-C52H8
Cynomolgus IL-2 R alpha / CD25 Protein, His Tag, low endotoxin (MALS verified)
Cynomolgus
HEK293
MALSSDS-PAGE
ELISA

$310.00

100ug
IL-2 R alpha
HOT
ILA-H52H9
Human IL-2 R alpha / CD25 Protein, His Tag, low endotoxin (Mass Spec & MALS verified)
Human
HEK293
MALSSDS-PAGE
ELISASPRBLICELL BASE

$375.00

100ug
IL-2 R alpha
HOTAvitag
ILA-H82E6
Biotinylated Human IL-2 R alpha / CD25 Protein, His,Avitag™, premium grade
Human
HEK293
MALSSDS-PAGE
ELISABLICELL BASE

$360.00

25ug
IL-2 R alpha
HOT
ILA-H5251
Human IL-2 R alpha / CD25 Protein, Fc Tag, low Endotoxin (MALS verified)
Human
HEK293
MALSSDS-PAGE
ELISASPRBLI

$325.00

100ug
IL-2 R alpha
HOT
ILA-M52H9
Mouse IL-2 R alpha / CD25 Protein, His Tag (MALS verified)
Mouse
HEK293
MALSSDS-PAGE
ELISABLI

$340.00

100ug
IL-2 R alpha
ILA-C52H4
Canine IL-2 R alpha / CD25 Protein, His Tag
Canine
HEK293
SDS-PAGE
ELISA

$310.00

100ug
IL-2 R alpha
Avitag
ILA-C82E4
Biotinylated Cynomolgus IL-2 R alpha / CD25 Protein, His,Avitag™ (MALS verified)
Cynomolgus
HEK293
MALSSDS-PAGE
ELISASPR

$360.00

25ug
IL-2 R alpha
Avitag
ILA-H82F9
Biotinylated Human IL-2 R alpha / CD25 Protein, Fc,Avitag™ (MALS verified)
Human
HEK293
MALSSDS-PAGE
ELISA

$360.00

25ug
IL-2 R alpha
Avitag
ILA-M82E9
Biotinylated Mouse IL-2 R alpha / CD25 Protein, His,Avitag™ (MALS verified)
Mouse
HEK293
MALSSDS-PAGE
ELISASPR

$360.00

25ug
You Have Viewed 1-10 Of 12 Results
  • 1
  • 2

Can’t find what you need?

Submit your requirements and our technical
team will help.

제품 문의Request Customization
Asset Licensing Opportunity

항체 프로젝트 거래 플랫폼

프로젝트 이름프로젝트 단계분자 유형분자 출처질병 영역적응증
CD25 mAb - 01PCCMonoclonalHumanized MouseSolid TumorSolid tumor
프로젝트 이름
CD25 mAb - 01
프로젝트 단계
PCC
분자 유형
Monoclonal
분자 출처
Humanized Mouse
질병 영역
Solid Tumor
적응증
Solid tumor
Resources

임상 약물 정보

영어 이름연구 코드연구 개발 단계회사적응증임상 시험
Basiliximab biobetter (Mabtech/Sorrento)STI-003Phase 3 ClinicalTaizhou Maibo Taike Biotechnology Co Ltd
Autoimmune Diseases
상세
LMB-2LMB-2; LMB-2aPhase 2 ClinicalNational Cancer Institute
Leukemia; Leukemia, Hairy Cell; Leukemia, T-Cell; Lymphoma; Myelodysplastic Syndromes; Myelodysplastic-Myeloproliferative Diseases; Myeloproliferative Disorders; Skin Melanoma; Skin Neoplasms
상세
Nemvaleukin alfaRDB-1419; RDB-1450; ALKS-4230Phase 2 ClinicalAlkermes Plc
Fallopian Tube Neoplasms; Melanoma; Ovarian Neoplasms; Peritoneal Neoplasms; Skin Melanoma; Solid tumours; Squamous Cell Carcinoma of Head and Neck
상세
Camidanlumab tesirineADCT-301Phase 2 ClinicalAdc Therapeutics Sa, Genmab A/S
Carcinoma, Non-Small-Cell Lung; Carcinoma, Renal Cell; Colorectal Neoplasms; Esophageal Neoplasms; Fallopian Tube Neoplasms; Hodgkin Disease; Leukemia, Myeloid, Acute; Lymphoma, Non-Hodgkin; Melanoma; Myelodysplastic Syndromes; Myeloproliferative Disorders; Ovarian Neoplasms; Pancreatic Neoplasms; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Squamous Cell Carcinoma of Head and Neck; Stomach Neoplasms; Triple Negative Breast Neoplasms; Urinary Bladder Neoplasms
상세
90Y-HAT (NCI)Phase 2 ClinicalNational Cancer Institute
Hodgkin Disease; Lymphoma, Non-Hodgkin
상세
Humanized Anti-CD25 Antibody(Institute of Hematology & Blood Diseases Hospital)Phase 2 ClinicalInstitute Of Hematology & Blood Diseases Hospital
Graft vs Host Disease
상세
90Y BasiliximabPhase 2 ClinicalCity Of Hope National Medical Center
Hodgkin Disease; Leukemia, Myeloid, Acute; Lymphoma, Non-Hodgkin; Lymphoma, T-Cell; Lymphoma, T-Cell, Cutaneous; Myelodysplastic Syndromes; Precursor Cell Lymphoblastic Leukemia-Lymphoma
상세
PT-101PT-101; MK-6194; PT101Phase 1 ClinicalPandion Therapeutics
Colitis, Ulcerative; Dermatitis, Atopic; Lupus Erythematosus, Systemic; Vitiligo
상세
Anti-interleukin-2 receptor monoclonal antibody Mikbeta1HuMikβ1-1Phase 1 ClinicalF. Hoffmann-La Roche Ltd, National Institutes Of Health
Celiac Disease; Leukemia; Leukemia, Large Granular Lymphocytic; Leukemia, Lymphoid; Paraparesis, Tropical Spastic
상세
BA-1106TS-1904; BA-1106; RR-102Phase 1 ClinicalShandong Boan Biotechnology Co Ltd
Solid tumours
상세
XmAb-564XmAb-564; XmAb564; XmAb-27564Phase 1 ClinicalXencor Inc
Autoimmune Diseases; Dermatitis, Atopic; Psoriasis
상세
PF-08046032PF-08046032Phase 1 ClinicalPfizer Inc
Carcinoma, Non-Small-Cell Lung; Hodgkin Disease; Lymphoma, Large B-Cell, Diffuse; Lymphoma, T-Cell, Peripheral; Melanoma; Neoplasms; Squamous Cell Carcinoma of Head and Neck
상세
IL2 CD25 fusion protein (Bristol-Myers Squibb)Phase 1 ClinicalUniversity Of Miami
Autoimmune Diseases
상세
9MW-39119MW3911; 9MW-3911Phase 1 ClinicalNanjing Nuo Aixin Biotechnology Co Ltd
Neoplasms
상세
In 111-DOTA-BasiliximabPhase 1 ClinicalCity Of Hope National Medical Center
Leukemia, Myeloid, Acute; Myelodysplastic Syndromes; Precursor Cell Lymphoblastic Leukemia-Lymphoma
상세
BMS-986326BMS-986326Phase 1 ClinicalBristol-Myers Squibb Company
Dermatitis, Atopic; Lupus Vulgaris
상세

시판 약물 정보

영어 이름연구 코드연구 개발 단계회사가장 빠른 브랜드 이름가장 빠른 승인 국가가장 빠른 적응증가장 빠른 승인 회사가장 빠른 승인 날짜적응증임상 시험
Daclizumab biosimilar (Shanghai CP Guojian)ApprovedSunshine GuoJian Pharmaceutical (Shanghai) Co Ltd健尼哌Mainland ChinaRejection of renal transplantationnull2011-01-12
Rejection of renal transplantation
상세
DaclizumabR-35; BIIB-019; RO-247375ApprovedAbbvie Inc, Biogen Inc, F. Hoffmann-La Roche LtdZinbryta, ZenapaxUnited StatesRejection of organ transplantationF. Hoffmann-La Roche Ag1997-12-10
Anemia, Aplastic; Anemia, Diamond-Blackfan; Arthritis, Juvenile; Asthma; Behcet Syndrome; Breast Neoplasms; Carcinoma, Ductal; Colitis, Ulcerative; Diabetes Mellitus, Type 1; Gastrointestinal Diseases; Granulomatosis with Polyangiitis; HIV Infections; HTLV-I Infections; Inflammatory Bowel Diseases; Iritis; Leukemia; Leukemia, T-Cell; Lymphoma; Melanoma; Multiple Sclerosis; Multiple Sclerosis, Relapsing-Remitting; Myelodysplastic Syndromes; Psoriasis; Radiation Injuries; Red-Cell Aplasia, Pure; Rejection in heart transplantation; Rejection of organ transplantation; Retinal Diseases; Thrombocytopenia; Uveitis; Uveitis, Anterior
상세
BasiliximabCHT-25; chRFT5; CHI-621; SDZ-CHI-621ApprovedNovartis Pharma Ag舒莱, SimulectUnited StatesRejection of organ transplantationNovartis Pharma Ag1998-05-12
Anemia, Aplastic; Colitis, Ulcerative; Coronavirus Disease 2019 (COVID-19); Cytokine Release Syndrome; Emphysema; Hemoglobinuria, Paroxysmal; Hodgkin Disease; Keratoplasty rejection; Kidney Failure, Chronic; Leukemia, Lymphocytic, Chronic, B-Cell; Leukemia, Myelogenous, Chronic; Leukemia, Myeloid, Acute; Lymphoma, Non-Hodgkin; Multiple Myeloma; Myelodysplastic Syndromes; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Primary Myelofibrosis; Pulmonary Disease, Chronic Obstructive; Rejection of renal transplantation; Rejection of organ transplantation; Uveitis
상세
Customer Reviews
  • E***n2023-04-08
    Human IL-2 R alpha / CD25 Protein, His Tag, low endotoxin (Mass Spec & MALS verified)
    Yeast cells expressing and displaying different IL2 variants were incubated 1h in the presence of CD25 protein with His tag (Human Il-2 R alpha Acrobiosystems #ILA-H52H9) at a final concentration of 4µg/ml. Next, cells were washed and incubated with a mouse Anti-His-PE. The yeast cells were washed and were analyzed using FACS. We observed detectable amounts of fluorescence bound to yeast cells displaying specific IL2 variants confirming that CD25 could bind to certain constructs and providing evidence that certain IL2 variants were correctly folded.
  • 1***22022-08-03
    Mouse IL-2 R alpha / CD25 Protein, His Tag (MALS verified)
    I purchased the company’s mouse-derived CD25 protein for the evaluation of CD25 antibody affinity. It achieved a high sensitivity detection with a small amount! Very satisfied, will come back to purchase more if needed!